Cassaday & Co Wealth Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 32.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,930 shares of the healthcare conglomerate’s stock after selling 2,818 shares during the period. Cassaday & Co Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,605,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Johnson Financial Group Inc. raised its position in shares of UnitedHealth Group by 2.2% during the 1st quarter. Johnson Financial Group Inc. now owns 15,029 shares of the healthcare conglomerate’s stock worth $4,067,000 after acquiring an additional 329 shares in the last quarter. Element Pointe Advisors LLC increased its stake in UnitedHealth Group by 6.2% in the first quarter. Element Pointe Advisors LLC now owns 2,353 shares of the healthcare conglomerate’s stock valued at $637,000 after purchasing an additional 138 shares during the last quarter. JSF Financial LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $506,000. Commerzbank Aktiengesellschaft FI boosted its holdings in shares of UnitedHealth Group by 44.0% in the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 99,608 shares of the healthcare conglomerate’s stock valued at $26,953,000 after buying an additional 30,432 shares in the last quarter. Finally, Florida Financial Advisors LLC raised its stake in UnitedHealth Group by 22.0% during the 1st quarter. Florida Financial Advisors LLC now owns 2,257 shares of the healthcare conglomerate’s stock worth $611,000 after acquiring an additional 407 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Barclays raised its price target on UnitedHealth Group (UNH) to $441 from $429 and reiterated an overweight rating, reinforcing bullish sentiment around the stock’s post-earnings setup. Barclays raises UnitedHealth price target
- Positive Sentiment: Truist, Oppenheimer, and KeyBanc also lifted targets to $500, signaling that analysts see more room for UnitedHealth’s shares to run after the strong quarterly report. Wall Street sees more room to run
- Positive Sentiment: Media coverage highlighted UnitedHealth as a momentum stock, with several articles asking whether the recent strength and earnings performance make UNH an attractive buy for growth-oriented investors. Yahoo Finance momentum stock article
- Neutral Sentiment: Congress passed H.R. 8823, a bill aimed at strengthening provider accountability in FECA. While the measure could increase compliance scrutiny for healthcare providers, its direct financial impact on UnitedHealth is uncertain at this stage. House passes FECA accountability bill
- Negative Sentiment: One article flagged that UnitedHealth’s CFO warned that cost pressures are still not fully solved, suggesting that margin concerns could temper enthusiasm despite the earnings beat. CFO warning after earnings
UnitedHealth Group Stock Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same quarter last year, the business earned $4.08 EPS. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 18.77 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 59.72%.
Analyst Upgrades and Downgrades
UNH has been the topic of several research reports. Wells Fargo & Company raised their price objective on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Leerink Partners upped their target price on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a research report on Wednesday, June 17th. UBS Group lifted their price target on UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a research report on Wednesday, May 27th. Finally, Morgan Stanley upped their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $449.17.
Check Out Our Latest Research Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Read More
- Five stocks we like better than UnitedHealth Group
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
